UGT1A1*6 AND UGT1A1*27 ARE ASSOCIATED WITH IRINOTECAN-INDUCED SEVERE NEUTROPENIA IN JAPANESE PATIENTS WITH NSCLC

被引：0
|
作者：
Doi, S. [1 ]
Nakamura, Y. [1 ]
Fukuda, M. [2 ,3 ]
Takatani, H. [2 ]
Fukuda, M. [2 ,3 ]
Kinoshita, A. [4 ]
Soda, H. [5 ]
Oka, M. [6 ]
Tsukamoto, K. [7 ]
Kohno, S. [1 ]
机构：
[1] Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 852, Japan
[2] Japanese Red Cross Nagasaki Atom Bomb Hosp, Nagasaki, Japan
[3] Nagasaki Municipal Hosp, Nagasaki, Japan
[4] NHO Nagasaki Med Ctr, Ohmura, Japan
[5] Sasebo Gen Hosp, Sasebo, Japan
[6] Kawasaki Med Sch, Div Resp Dis, Kurashiki, Okayama 70101, Japan
[7] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharmacotherapeut, Nagasaki 852, Japan
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：165 / 165
页数：1
相关论文
共 50 条
  • [21] Correlation of UGT1A1*28 and *6 polymorphisms with irinotecan-induced neutropenia in Thai colorectal cancer patients
    Atasilp, Chalirmporn
    Chansriwong, Pichai
    Sirachainan, Ekapob
    Reungwetwattana, Thanyanan
    Chamnanphon, Montri
    Puangpetch, Apichaya
    Wongwaisayawan, Sansanee
    Sukasem, Chonlaphat
    DRUG METABOLISM AND PHARMACOKINETICS, 2016, 31 (01) : 90 - 94
  • [22] Relevance of CYP3A4*20, UGT1A1*37 and UGT1A1*28 variants in irinotecan-induced severe toxicity
    Riera, Pau
    Salazar, Juliana
    Virgili, Anna C.
    Tobena, Maria
    Sebio, Ana
    Gallano, Pia
    Barnadas, Agusti
    Paez, David
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (06) : 1389 - 1392
  • [23] Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1
    de With, Mirjam
    van Doorn, Leni
    Kloet, Esmay
    van Veggel, Anne
    Matic, Maja
    de Neijs, Micha J.
    de Hoop, Esther
    van Meerten, Esther
    van Schaik, Ron H. N.
    Mathijssen, Ron H. J.
    Bins, Sander
    CLINICAL PHARMACOKINETICS, 2023, 62 (11) : 1589 - 1597
  • [24] Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1
    Mirjam de With
    Leni van Doorn
    Esmay Kloet
    Anne van Veggel
    Maja Matic
    Micha J. de Neijs
    Esther Oomen - de Hoop
    Esther van Meerten
    Ron H. N. van Schaik
    Ron H. J. Mathijssen
    Sander Bins
    Clinical Pharmacokinetics, 2023, 62 : 1589 - 1597
  • [25] Re:: UGT1A1*28 genotype and irinotecan-induced neutropenia:: Dose matters -: Reply
    Hoskins, Janelle M.
    McLeod, Howard L.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (03)
  • [26] UGT1A1*28 polymorphism linked to irinotecan-induced ADRs
    Reactions Weekly, 2008, 1207 (1) : 4 - 4
  • [27] Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients
    Jada, Srinivasa Rao
    Lim, Robert
    Wong, Chiung Ing
    Shu, Xiaochen
    Lee, Soo Chin
    Zhou, Qingyu
    Goh, Boon Cher
    Chowbay, Balram
    CANCER SCIENCE, 2007, 98 (09): : 1461 - 1467
  • [28] UGT1A1*6/*28 polymorphisms could predict irinotecan-induced severe neutropenia not diarrhea in Chinese colorectal cancer patients
    Jing Gao
    Jun Zhou
    Yanyan Li
    Ming Lu
    Ru Jia
    Lin Shen
    Medical Oncology, 2013, 30
  • [29] UGT1A1*6/*28 polymorphisms could predict irinotecan-induced severe neutropenia not diarrhea in Chinese colorectal cancer patients
    Gao, Jing
    Zhou, Jun
    Li, Yanyan
    Lu, Ming
    Jia, Ru
    Shen, Lin
    MEDICAL ONCOLOGY, 2013, 30 (03)
  • [30] ROLE OF UGT1A1*6 IN IRINOTECAN TOXICITY IN JAPANESE CANCER PATIENTS
    Kakihata, K.
    Sai, K.
    Mori, A.
    Saito, Y.
    Suzuki, T.
    Ando, Y.
    Hasegawa, Y.
    Sawada, J.
    Yoshida, T.
    ANNALS OF ONCOLOGY, 2008, 19 : 50 - 50
12345